Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marta Tiffany Lombardo"'
Autor:
Marta Tiffany Lombardo, Martina Gabrielli, Florence Julien-Marsollier, Valérie Faivre, Tifenn Le Charpentier, Cindy Bokobza, Deborah D’Aliberti, Nicola Pelizzi, Camilla Halimi, Silvia Spinelli, Juliette Van Steenwinckel, Elisabetta A. M. Verderio, Pierre Gressens, Rocco Piazza, Claudia Verderio
Publikováno v:
Cells, Vol 13, Iss 19, p 1665 (2024)
Human mesenchymal stem cells modulate the immune response and are good candidates for cell therapy in neuroinflammatory brain disorders affecting both adult and premature infants. Recent evidence indicates that through their secretome, mesenchymal st
Externí odkaz:
https://doaj.org/article/51f5f8caafe84d5a93b4ae59d295eef5
Autor:
Alicia Gómez-Pascual, Talel Naccache, Jin Xu, Koroush Hooshmand, Asger Wretlind, Martina Gabrielli, Marta Tiffany Lombardo, Liu Shi, Noel J. Buckley, Betty M. Tijms, Stephanie J. B. Vos, Mara ten Kate, Sebastiaan Engelborghs, Kristel Sleegers, Giovanni B. Frisoni, Anders Wallin, Alberto Lleó, Julius Pop, Pablo Martinez-Lage, Johannes Streffer, Frederik Barkhof, Henrik Zetterberg, Pieter Jelle Visser, Simon Lovestone, Lars Bertram, Alejo J. Nevado-Holgado, Petroula Proitsi, Claudia Verderio, Juan A. Botía, Cristina Legido-Quigley
Mild Cognitive Impairment (MCI) is a phase that can precede Alzheimer's Disease (AD). To better understand the molecular mechanisms underlying conversion from MCI to AD, we proposed a multiomics machine learning pipeline (four algorithms) to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df7029d5eb866c304ac63275859d5c15
https://doi.org/10.1101/2023.03.02.23286674
https://doi.org/10.1101/2023.03.02.23286674
Autor:
Silvia Pellegrini, Valentina Zamarian, Elisa Landi, Alessandro Cospito, Marta Tiffany Lombardo, Fabio Manenti, Antonio Citro, Marco Schiavo Lena, Lorenzo Piemonti, Valeria Sordi
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 17; Pages: 9699
Int J Mol Sci.
Int J Mol Sci.
Insulin-producing cells derived from induced pluripotent stem cells (iPSCs) are promising candidates for β cell replacement in type 1 diabetes. However, the risk of teratoma formation due to residual undifferentiated iPSCs contaminating the differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e28135b69c4770c264550d3a7240620
https://pubmed.ncbi.nlm.nih.gov/36077097
https://pubmed.ncbi.nlm.nih.gov/36077097
Autor:
Maurizio Ferrari, Giovanni Battista Pipitone, Gianvito Martino, Lorenzo Piemonti, Fabio Manenti, Gaia Poggi, Paola Carrera, Rita Nano, Silvia Pellegrini, Marta Tiffany Lombardo, Valeria Sordi, Alessandro Cospito
Publikováno v:
J Clin Endocrinol Metab.
ContextMaturity-onset diabetes of the young (MODY) 8 is a rare form of monogenic diabetes characterized by a mutation in CEL (carboxyl ester lipase) gene, which leads to exocrine pancreas dysfunction, followed by β cell failure. Induced pluripotent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3305f5b5b10f20ce401b8740767c2d21
https://doi.org/10.1210/clinem/dgaa986
https://doi.org/10.1210/clinem/dgaa986
Autor:
Raniero, Chimienti, Tania, Baccega, Silvia, Torchio, Fabio, Manenti, Silvia, Pellegrini, Alessandro, Cospito, Angelo, Amabile, Marta Tiffany, Lombardo, Paolo, Monti, Valeria, Sordi, Angelo, Lombardo, Mauro, Malnati, Lorenzo, Piemonti
Publikováno v:
Cell reports. 40(13)
Induced pluripotent stem cells (iPSCs) represent a source from which β cells can be derived for diabetes replacement therapy. However, their application may be hindered by immune-mediated responses. Although abrogation of major histocompatibility co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e91834c9e005691b2297caffdd1273e7
https://pubmed.ncbi.nlm.nih.gov/36170817
https://pubmed.ncbi.nlm.nih.gov/36170817
Autor:
Raniero Chimienti, G. Frontino, Lorenzo Piemonti, S. Torchio, Valeria Sordi, F. Meschi, Fabio Manenti, G. Rossi, V. Broccoli, Marta Tiffany Lombardo, Silvia Pellegrini
Publikováno v:
Cytotherapy. 23:S121-S122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a73fc3e1e68aa7a70c074a655d29d6d
https://doi.org/10.1016/s1465324921004710
https://doi.org/10.1016/s1465324921004710
Autor:
V. Zamarian, Marta Tiffany Lombardo, Silvia Pellegrini, Lorenzo Piemonti, Fabio Manenti, Valeria Sordi, E. Landi
Publikováno v:
Cytotherapy. 23:S124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32d144bc2f27ee4176daf96fd5d42e7e
https://doi.org/10.1016/s1465324921004771
https://doi.org/10.1016/s1465324921004771
Autor:
Marta Tiffany Lombardo, Fabio Manenti, Francesca Giannese, Gaia Poggi, Lorenzo Piemonti, Rita Nano, Silvia Pellegrini, Raniero Chimienti, G. Scotti, Alessandro Cospito, Valeria Sordi, Dejan Lazarevic
Publikováno v:
Cytotherapy
Background aims Induced pluripotent stem cells (iPSCs) have the capacity to generate β cells in vitro, but the differentiation is incomplete and generates a variable percentage of off-target cells. Single-cell RNA sequencing offers the possibility o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13911e5b341f0e46d44334c5681a641d
Autor:
Raniero Chimienti, Tania Baccega, Silvia Torchio, Fabio Manenti, Silvia Pellegrini, Alessandro Cospito, Angelo Amabile, Marta Tiffany Lombardo, Paolo Monti, Valeria Sordi, Angelo Lombardo, Mauro Malnati, Lorenzo Piemonti
Publikováno v:
Cell Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6446c626b85e83fabed75816896e0cc